Alira Health

Alira Health

Alira Health Strengthens Clinical Operations with the Acquisition of Sourcia

Complements Alira Health’s Established US and EU Mediterranean Clinical Operations with a Strong Central European Presence

FRAMINGHAM, Mass. – April 5, 2022– Alira Health, a global health care advisory and technology company, announced that it has acquired a full-service Contract Research Organization (CRO), Sourcia, that provides services for Phase I to Phase IV clinical trials with a focus on biotech, medical devices, and digital therapeutics. Founded in 2012, Sourcia is based in Europe, with headquarters in Zevenbergen, The Netherlands, and operational offices in Munich, Germany, and Vienna, Austria.

Benjamin Chambon

Benjamin Chambon

CCO and Co-Founder,

Alira Health

The increasing need for time-efficient and cost-effective drug development is driving demand for CRO services.  We believe that Sourcia’s integrated outsourcing model is particularly suited to the needs of today’s market,” said Benjamin Chambon, Chief Commercial Officer of Alira Health. “Sourcia is a well-established player in the European CRO market with a deeply experienced leadership team and a strong reputation in the VC community for a pattern of innovation. We are incredibly honored to welcome them to Alira Health.”

Verena Koepke

Verena Koepke

Managing Partner, Sourcia

 

Sourcia’s unique integrated outsourcing model lets biotech and MedTech clients manage clinical trials with the highest level of effectiveness, efficiency, and trust”, said Verena Koepke, Managing Partner of Sourcia. “We are extremely pleased to become part of Alira Health and expand our capabilities of full-service clinical work. Alira Health’s broad range of tech-enabled consulting and advisory services, complemented by its mission to humanize healthcare, is where our industry is headed.”

About Sourcia

Sourcia founded in 2012, is a Contract Research Organization, that specifically focuses on providing clinical trial services for Phase I to Phase IV / Pre- and Post CE marking-related clinical trials. Sourcia is located in Europe with its Headquarters in Zevenbergen, The Netherlands, and with its operational offices in Munich, Germany, and Vienna, Austria. Sourcia’s target is to focus on small-to-medium-sized biotech and medical device companies located in Europe. The team has years of practical experience and will support its clients on the road to success by finding the best-unbiased outsourcing solution for them and their businesses.

Learn more at www.sourcia.eu.

 

Related news

Reports May 20, 2024
Innovative Payment Schemes for Medtech in England, Germany, and France
This overview offers high-level details on the innovative payment schemes in England, Germany, and France.
MedTech
Case Studies May 14, 2024
Medtech Company Creates an Early Go-to-Market Strategy for Its Breakthrough IVD Solution
The client needed an early go-to-market strategy for their IVD solution to prepare for product development and launch in key European countries and the US.
IVDR Medical Devices MedTech
Case Studies May 8, 2024
Mid-Size Medtech Company with a Borderline Product Defines Strategy for EU Launch
Medtech company sought support in developing a regulatory strategy for the EU launch of their product with an aggressive timeline to launch.
Medical Devices MedTech Regulatory
Reports May 8, 2024
Value-Based Procurement in Australia
This white paper discusses why value-based healthcare and procurement are solutions in a robust healthcare system and identifies the medical technology sector as a collaborative partner(...)
MedTech Value-Based Contracts
Articles May 3, 2024
Successful Patient Advisory Boards: What Sponsors Need to Know
Discover five essential keys to a successful Patient Advisory Board (PAB) that can provide actionable feedback to guide you on all stages of development.
Patient Centricity Patient Engagement
Case Studies April 30, 2024
Medtech Company Leverages Bayesian Clinical Trial Design to Address FDA Feedback
A global medtech company needed help to address FDA feedback on their implant design that included a comparator and clearly demonstrated the safety and performance of this new device.
Clinical Trials Complex Innovative Design MedTech
Events April 30, 2024
The MedTech Forum 2024
We are thrilled to announce that we will exhibit and speak at The MedTech Forum 2024.
MedTech Regulatory
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.